Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 335

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 335
---

change of control or takeover transactions involving us.

In
addition, our amended and restated articles of incorporation and amended and restated bylaws contain provisions that may make it more
difficult for a third party to acquire us or increase the cost of acquiring us, even if doing so would benefit our shareholders, including
transactions in which shareholders might otherwise receive a premium for their shares. These provisions include:

    ●
    nothing
    in our amended and restated articles of incorporation precludes future issuances without shareholder approval of the authorized but
    unissued shares of our common stock;

    ●
    advance
    notice procedures apply for shareholders to nominate candidates for election as directors or to bring matters before an annual meeting
    of shareholders;

    ●
    a
    special meeting of shareholders can only be called by our chairman of the board of directors, our chief executive officer, our president
    (in the absence of a chief executive officer), a majority of our board of directors or the holders of 10% or more of all of our votes
    entitled to be cast on any issue proposed to be considered at the special meeting of shareholders;

    ●
    no
    provision in our amended and restated articles of incorporation or amended and restated bylaws provides for cumulative voting, which
    limits the ability of minority shareholders to elect director candidates; directors will only be able to be removed for cause;

    ●
    our
    amended and restated articles of incorporation authorizes undesignated preferred stock, the terms of which may be established and
    shares of which may be issued, without the approval of the holders of our capital stock; and

    ●
    certain
    litigation against us can only be brought in Florida.

44

These
provisions could discourage, delay or prevent a transaction involving a change in control of our company. These provisions could also
discourage proxy contests and make it more difficult for you and other shareholders to elect directors of your choosing and cause us
to take corporate actions other than those you desire. See “Description of Capital Stock.”

Our
amended and restated bylaws designates the state courts located within the state of Florida as the exclusive forum for substantially
all disputes between us and our shareholders and the federal district courts as the exclusive forum for Securities Act claims, which
could limit our shareholders’ ability to obtain a favorable judicial forum for disputes with us.

Our
amended and restated bylaws provide that, unless we consent in